Merck flags decline in operating profit of up to 10 percent in 2023 Ruchika Sharma14 May 2023 6:00 AM GMTGermany: Germany's Merck KGaA on Thursday warned that adjusted operating earnings could decline by as much as 10% this year as the outlook for...
Merck appoints Helene von Roeder as new CFO Ruchika Sharma9 May 2023 11:00 AM GMTDarmstadt: Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board of Merck as of June 30, 2023. He...
Bristol Myers Squibb gets USFDA priority review for expanded Reblozyl use Ruchika Sharma1 May 2023 12:01 PM GMTReblozyl, a first-in-class therapeutic option, promotes late-stage red blood cell maturation in animal models.
Merck beats first-quarter expectations on Keytruda, Gardasil strength Ruchika Sharma30 April 2023 10:30 AM GMTBengaluru: Drugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster...
USFDA panel backs restricted use of AstraZeneca Prostrate cancer drug Ruchika Sharma29 April 2023 7:00 AM GMTLynparza belongs to a class of drugs called PARP inhibitors, which include Clovis Oncology's Rubraca and GSK Plc's Zejula.
Glenmark to settle US lawsuits over generic drug for over Rs 715 crore Ruchika Sharma26 April 2023 10:58 AM GMTThe settlements will make clear that the company denies each and every one of the allegations against it and the settlements are not on the basis of...
Merck-Moderna vaccine helps keep patients free from skin cancer Roshni Dhar17 April 2023 12:30 PM GMTAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by...
Health Bulletin 17/April/2023 Roshni Dhar17 April 2023 10:59 AM GMTHere are the top health stories for the day:NEET UG 2023: NTA revises eligibility criteria for Indian candidates abroadThe NEET exam conducting body...
Moderna, Merck cancer vaccine plus Keytruda delays skin cancer return Ruchika Sharma17 April 2023 10:29 AM GMTThe vaccine is custom-built based on an analysis of a patient's tumors after surgical removal.
Merck to acquire Prometheus Biosciences for USD 11 billion Ruchika Sharma17 April 2023 7:00 AM GMTRahway: Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. have announced that the companies have entered into...
USFDA pauses initiation of new patients on multiple sclerosis evobrutinib drug: Merck Ruchika Sharma15 April 2023 5:49 AM GMTThe company must now place on hold the initiation of new evobrutinib patients and halt studies involving patients who have been taking the drug for...
USFDA accepts application for Merck KEYTRUDA plus Chemotherapy as first line treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Ruchika Sharma14 April 2023 5:30 AM GMTKEYTRUDA is an anti-programmed death receptor-1 therapy that works by increasing the ability of the body's immune system to help detect and fight...
